NOVO-NORDISK A/S-SPONS ADR (NVO) Fundamental Analysis & Valuation

NYSE:NVO • US6701002056

38.79 USD
+0.07 (+0.18%)
Last: Mar 11, 2026, 03:43 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This NVO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Overall NVO gets a fundamental rating of 6 out of 10. We evaluated NVO against 193 industry peers in the Pharmaceuticals industry. NVO scores excellent on profitability, but there are some minor concerns on its financial health. NVO scores decently on growth, while it is valued quite cheap. This could make an interesting combination. NVO also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

9

1. NVO Profitability Analysis

1.1 Basic Checks

  • NVO had positive earnings in the past year.
  • NVO had a positive operating cash flow in the past year.
  • Each year in the past 5 years NVO has been profitable.
  • Each year in the past 5 years NVO had a positive operating cash flow.
NVO Yearly Net Income VS EBIT VS OCF VS FCFNVO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

1.2 Ratios

  • NVO has a better Return On Assets (18.87%) than 96.89% of its industry peers.
  • NVO has a better Return On Equity (52.79%) than 98.45% of its industry peers.
  • The Return On Invested Capital of NVO (30.79%) is better than 97.93% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for NVO is significantly above the industry average of 13.09%.
  • The 3 year average ROIC (43.61%) for NVO is well above the current ROIC(30.79%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 18.87%
ROE 52.79%
ROIC 30.79%
ROA(3y)22.39%
ROA(5y)22.95%
ROE(3y)67.23%
ROE(5y)67.14%
ROIC(3y)43.61%
ROIC(5y)44.74%
NVO Yearly ROA, ROE, ROICNVO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • With an excellent Profit Margin value of 33.14%, NVO belongs to the best of the industry, outperforming 95.85% of the companies in the same industry.
  • NVO's Profit Margin has been stable in the last couple of years.
  • Looking at the Operating Margin, with a value of 41.30%, NVO belongs to the top of the industry, outperforming 97.93% of the companies in the same industry.
  • NVO's Operating Margin has been stable in the last couple of years.
  • Looking at the Gross Margin, with a value of 80.98%, NVO belongs to the top of the industry, outperforming 84.97% of the companies in the same industry.
  • In the last couple of years the Gross Margin of NVO has remained more or less at the same level.
Industry RankSector Rank
OM 41.3%
PM (TTM) 33.14%
GM 80.98%
OM growth 3Y-1.15%
OM growth 5Y-0.81%
PM growth 3Y1.84%
PM growth 5Y-0.03%
GM growth 3Y-1.18%
GM growth 5Y-0.61%
NVO Yearly Profit, Operating, Gross MarginsNVO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. NVO Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), NVO is creating value.
  • The number of shares outstanding for NVO remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for NVO has been increased compared to 5 years ago.
  • Compared to 1 year ago, NVO has a worse debt to assets ratio.
NVO Yearly Shares OutstandingNVO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
NVO Yearly Total Debt VS Total AssetsNVO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100B 200B 300B 400B 500B

2.2 Solvency

  • An Altman-Z score of 3.65 indicates that NVO is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of NVO (3.65) is better than 70.47% of its industry peers.
  • The Debt to FCF ratio of NVO is 4.52, which is a neutral value as it means it would take NVO, 4.52 years of fcf income to pay off all of its debts.
  • NVO has a Debt to FCF ratio of 4.52. This is amongst the best in the industry. NVO outperforms 83.94% of its industry peers.
  • NVO has a Debt/Equity ratio of 0.61. This is a neutral value indicating NVO is somewhat dependend on debt financing.
  • NVO's Debt to Equity ratio of 0.61 is on the low side compared to the rest of the industry. NVO is outperformed by 65.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 4.52
Altman-Z 3.65
ROIC/WACC4.58
WACC6.72%
NVO Yearly LT Debt VS Equity VS FCFNVO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.3 Liquidity

  • NVO has a Current Ratio of 0.80. This is a bad value and indicates that NVO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NVO has a worse Current ratio (0.80) than 87.56% of its industry peers.
  • A Quick Ratio of 0.57 indicates that NVO may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.57, NVO is doing worse than 86.53% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.57
NVO Yearly Current Assets VS Current LiabilitesNVO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B 200B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. NVO Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.77% over the past year.
  • Measured over the past years, NVO shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.66% on average per year.
  • NVO shows a small growth in Revenue. In the last year, the Revenue has grown by 6.43%.
  • The Revenue has been growing by 19.48% on average over the past years. This is quite good.
EPS 1Y (TTM)1.77%
EPS 3Y23.52%
EPS 5Y20.66%
EPS Q2Q%-4.73%
Revenue 1Y (TTM)6.43%
Revenue growth 3Y20.43%
Revenue growth 5Y19.48%
Sales Q2Q%-7.63%

3.2 Future

  • Based on estimates for the next years, NVO will show a small growth in Earnings Per Share. The EPS will grow by 5.80% on average per year.
  • The Revenue is expected to grow by 4.07% on average over the next years.
EPS Next Y-3.96%
EPS Next 2Y-2.8%
EPS Next 3Y1.16%
EPS Next 5Y5.8%
Revenue Next Year-4.65%
Revenue Next 2Y-0.75%
Revenue Next 3Y1.62%
Revenue Next 5Y4.07%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NVO Yearly Revenue VS EstimatesNVO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100B 200B 300B
NVO Yearly EPS VS EstimatesNVO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

7

4. NVO Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.81 indicates a reasonable valuation of NVO.
  • 89.12% of the companies in the same industry are more expensive than NVO, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of NVO to the average of the S&P500 Index (26.25), we can say NVO is valued rather cheaply.
  • A Price/Forward Earnings ratio of 11.24 indicates a reasonable valuation of NVO.
  • Based on the Price/Forward Earnings ratio, NVO is valued cheaply inside the industry as 86.53% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.39, NVO is valued rather cheaply.
Industry RankSector Rank
PE 10.81
Fwd PE 11.24
NVO Price Earnings VS Forward Price EarningsNVO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NVO indicates a rather cheap valuation: NVO is cheaper than 90.67% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, NVO is valued a bit cheaper than the industry average as 78.24% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 38.19
EV/EBITDA 8.08
NVO Per share dataNVO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The excellent profitability rating of NVO may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.52
EPS Next 2Y-2.8%
EPS Next 3Y1.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

8

5. NVO Dividend Analysis

5.1 Amount

  • NVO has a Yearly Dividend Yield of 4.71%, which is a nice return.
  • In the last 3 months the price of NVO has falen by -22.84%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 0.70, NVO pays a better dividend. On top of this NVO pays more dividend than 96.89% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, NVO pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.71%

5.2 History

  • The dividend of NVO is nicely growing with an annual growth rate of 19.05%!
  • NVO has been paying a dividend for at least 10 years, so it has a reliable track record.
  • NVO has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)19.05%
Div Incr Years7
Div Non Decr Years7
NVO Yearly Dividends per shareNVO Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 50.53% of the earnings are spent on dividend by NVO. This is a bit on the high side, but may be sustainable.
  • NVO's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP50.53%
EPS Next 2Y-2.8%
EPS Next 3Y1.16%
NVO Yearly Income VS Free CF VS DividendNVO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B
NVO Dividend Payout.NVO Dividend Payout, showing the Payout Ratio.NVO Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NVO Fundamentals: All Metrics, Ratios and Statistics

NOVO-NORDISK A/S-SPONS ADR

NYSE:NVO (3/11/2026, 3:43:07 PM)

38.79

+0.07 (+0.18%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-03
Earnings (Next)05-06
Inst Owners32.22%
Inst Owner Change3.18%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap172.49B
Revenue(TTM)309.06B
Net Income(TTM)102.43B
Analysts69.41
Price Target57.95 (49.39%)
Short Float %0.65%
Short Ratio1.07
Dividend
Industry RankSector Rank
Dividend Yield 4.71%
Yearly Dividend1.81
Dividend Growth(5Y)19.05%
DP50.53%
Div Incr Years7
Div Non Decr Years7
Ex-Date03-30
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.82%
Min EPS beat(2)-7.04%
Max EPS beat(2)1.39%
EPS beat(4)2
Avg EPS beat(4)-0.71%
Min EPS beat(4)-7.04%
Max EPS beat(4)3.94%
EPS beat(8)5
Avg EPS beat(8)1.01%
EPS beat(12)8
Avg EPS beat(12)1.47%
EPS beat(16)11
Avg EPS beat(16)1.68%
Revenue beat(2)1
Avg Revenue beat(2)-1.06%
Min Revenue beat(2)-3.19%
Max Revenue beat(2)1.07%
Revenue beat(4)1
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-3.19%
Max Revenue beat(4)1.07%
Revenue beat(8)3
Avg Revenue beat(8)0.15%
Revenue beat(12)6
Avg Revenue beat(12)0.52%
Revenue beat(16)9
Avg Revenue beat(16)0.84%
PT rev (1m)-9.11%
PT rev (3m)-11.49%
EPS NQ rev (1m)6.8%
EPS NQ rev (3m)0.84%
EPS NY rev (1m)-2.97%
EPS NY rev (3m)-7.34%
Revenue NQ rev (1m)-37.7%
Revenue NQ rev (3m)-50.96%
Revenue NY rev (1m)-4.89%
Revenue NY rev (3m)-6.85%
Valuation
Industry RankSector Rank
PE 10.81
Fwd PE 11.24
P/S 3.58
P/FCF 38.19
P/OCF 9.29
P/B 5.71
P/tB 17.3
EV/EBITDA 8.08
EPS(TTM)3.59
EY9.25%
EPS(NY)3.45
Fwd EY8.9%
FCF(TTM)1.02
FCFY2.62%
OCF(TTM)4.17
OCFY10.76%
SpS10.83
BVpS6.8
TBVpS2.24
PEG (NY)N/A
PEG (5Y)0.52
Graham Number23.44
Profitability
Industry RankSector Rank
ROA 18.87%
ROE 52.79%
ROCE 39.01%
ROIC 30.79%
ROICexc 33.56%
ROICexgc 59.2%
OM 41.3%
PM (TTM) 33.14%
GM 80.98%
FCFM 9.38%
ROA(3y)22.39%
ROA(5y)22.95%
ROE(3y)67.23%
ROE(5y)67.14%
ROIC(3y)43.61%
ROIC(5y)44.74%
ROICexc(3y)50.94%
ROICexc(5y)53.03%
ROICexgc(3y)100.46%
ROICexgc(5y)105.49%
ROCE(3y)55.75%
ROCE(5y)58.53%
ROICexgc growth 3Y-22.89%
ROICexgc growth 5Y-7.78%
ROICexc growth 3Y-18.13%
ROICexc growth 5Y-11.63%
OM growth 3Y-1.15%
OM growth 5Y-0.81%
PM growth 3Y1.84%
PM growth 5Y-0.03%
GM growth 3Y-1.18%
GM growth 5Y-0.61%
F-Score5
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 4.52
Debt/EBITDA 0.79
Cap/Depr 409.94%
Cap/Sales 29.16%
Interest Coverage 37.34
Cash Conversion 79.59%
Profit Quality 28.3%
Current Ratio 0.8
Quick Ratio 0.57
Altman-Z 3.65
F-Score5
WACC6.72%
ROIC/WACC4.58
Cap/Depr(3y)363.9%
Cap/Depr(5y)282.93%
Cap/Sales(3y)21.19%
Cap/Sales(5y)15.43%
Profit Quality(3y)60.31%
Profit Quality(5y)79.23%
High Growth Momentum
Growth
EPS 1Y (TTM)1.77%
EPS 3Y23.52%
EPS 5Y20.66%
EPS Q2Q%-4.73%
EPS Next Y-3.96%
EPS Next 2Y-2.8%
EPS Next 3Y1.16%
EPS Next 5Y5.8%
Revenue 1Y (TTM)6.43%
Revenue growth 3Y20.43%
Revenue growth 5Y19.48%
Sales Q2Q%-7.63%
Revenue Next Year-4.65%
Revenue Next 2Y-0.75%
Revenue Next 3Y1.62%
Revenue Next 5Y4.07%
EBIT growth 1Y-4.76%
EBIT growth 3Y19.04%
EBIT growth 5Y18.51%
EBIT Next Year8.51%
EBIT Next 3Y5.92%
EBIT Next 5Y7.75%
FCF growth 1Y-58.38%
FCF growth 3Y-23.26%
FCF growth 5Y-0.6%
OCF growth 1Y-1.54%
OCF growth 3Y14.72%
OCF growth 5Y18.05%

NOVO-NORDISK A/S-SPONS ADR / NVO FAQ

Can you provide the ChartMill fundamental rating for NOVO-NORDISK A/S-SPONS ADR?

ChartMill assigns a fundamental rating of 6 / 10 to NVO.


What is the valuation status of NOVO-NORDISK A/S-SPONS ADR (NVO) stock?

ChartMill assigns a valuation rating of 7 / 10 to NOVO-NORDISK A/S-SPONS ADR (NVO). This can be considered as Undervalued.


Can you provide the profitability details for NOVO-NORDISK A/S-SPONS ADR?

NOVO-NORDISK A/S-SPONS ADR (NVO) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for NVO stock?

The Price/Earnings (PE) ratio for NOVO-NORDISK A/S-SPONS ADR (NVO) is 10.81 and the Price/Book (PB) ratio is 5.71.


What is the financial health of NOVO-NORDISK A/S-SPONS ADR (NVO) stock?

The financial health rating of NOVO-NORDISK A/S-SPONS ADR (NVO) is 4 / 10.